Short answer
Outset Medical, Inc. (OM) filed an 8-K current report with the SEC on May 29, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Marc Nash departs June 5, 2026 as Executive Vice President, R&D, Operations and Service.
Outset Medical, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Marc Nash departs June 5, 2026 as Executive Vice President, R&D, Operations and Service
- Departure to pursue other professional opportunities, not related to a dispute with management
- Leadership transition spans product development, operations and customer service functions
- Filing identifies no successor or transition arrangements
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Outset Medical, Inc. 8-K filings
Get the next OM 8-K as it lands
Follow OM for push alerts, or ask the research agent what this filing means.